In lung cancer, ubiquitin ligase interleukin 17 receptor B (CRL4) and WD repeat domain 4 promotes the progression of lung cancer through ubiquitin degradation of the promyelocytic leukemia protein. This evidence concerns the gene PML and lung cancer.